Biological markers for the diagnosis of Alzheimer's disease

Journal of Neural Transmission, Supplement

Volumn , Issue 53, 1998, Pages 185-197

  Bancher, C ^a   Jellinger, K ^a   Wichart, I ^a  

^a GENERAL HOSPITAL LINZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; TAU PROTEIN; BIOLOGICAL MARKER;

ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; AGED; BRAIN; CEREBROSPINAL FLUID; METABOLISM; PATHOLOGY; REVIEW;

AGED; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; BRAIN; HUMANS;

EID: 0031596272     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6467-9_17     Document Type: Article

References (74)

1. Arai H, Terajima M, Miura M, Higuchi S, Muramatsu T, Machida N, Seiki H, Takase S, Clark CM, Lee VM-Y, Trojanowski JQ, Sasaki A (1995) Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease. Ann Neurol 38: 649-652
2. Arai H, Higuchi S, Sasaki H (1997) Apolipoprotein E genotyping and cerebrospinal fluid tau protein -implications for the clinical diagnosis of Alzheimer's disease. Gerontology 43 [Suppl 1]: 2-11
3. Bancher C, Brunner C, Lassmann H, Budka H, Jellinger K, Wiche G, Seitelberger F, Grundke-Iqbal I, Iqbal K, Wisniewski HM (1989) Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Res 477: 90-99
4. Bancher C, Wisniewski HM, Mehta PD, Kim KS, Grundke-Iqbal I, Iqbal K (1991) Biochemical markers for Alzheimer's disease as reflection of the neuropathology in cerebrospinal fluid. In: Becker RE, Giacobini E (eds) Current research in Alzheimer therapy II. Early diagnosis. Taylor and Francis, New York, pp 195-216
5. Blennow K, Hesse C, Fredman P (1994a) Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease. NeuroReport 5: 2534-2536
6. Blennow K, Davidsson P, Wallin A, Gottfries CG, Svennerholm L (1994b) First place. 1993 IPA research awards in psychogeriatrics: ubiquitin in cerebrospinal fluid in Alzheimer's disease and vascular dementia. Int Psychogeriatr 6: 13-22
7. Blennow K, Wallin A, Ekman R (1994c) Neuron specific enolase in cerebrospinal fluid: a biochemical marker for neurronal degeneration in dementia disorders? J Neural Transm [P-D Sect] 8: 183-191
8. Blennow K, Wallin A, Agren H, Spenger C, Siegfried J, Vanmechelen E (1995a) Tau protein in cerebrospinal fluid. A biochemical marker for axonal degeneration in Alzheimer disease? Mol Chem Neuropathol 26: 231-245
9. Blennow K, Davidsson P, Wallin A, Ekman R (1995b) Chromogranin A in cerebrospinal fluid: a biochemical marker for synaptic degeneration in Alzheimer's disease. Dementia 6: 306-311
10. Blennow K, Wallin A, Chong JK (1995c) Cerebrospinal fluid "neuronal thread protein" comes from serum by passage over the blood-brain barrier. Neurodegeneration 4: 187-193
11. Blomberg M, Jensen M, Basun H, Lannfelt L, Wahlund LO (1996) Increasing cerebrospinal fluid tau levels in a subgroup of Alzheimer patients with apolipoprotein E allele epsilon 4 during 14 months follow-up. Neurosci Lett 214: 163-166
12. Blum-Degen D, Muller T, Kuhn W, Gerlach M, Przuntek H, Riederer P (1995) Interleukin-1beta and interleukin 6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci Lett 202: 17-20
13. Csernansky JG, Bardgett ME, Sheline YI, Morris JC, Olney JW (1996) CSF excitatory amino acids and severity of illness in Alzheimer's disease. Neurology 46: 1715-1720
14. Davidsson P, Jahn R, Bergquist J, Ekman R, Blennow K (1996) Synaptotagmin, a synaptiv vesicle protein, is present in human ceerebrospinal fluid: a new biochemichal marker for synaptic pathology in Alzheimer disease? Mol Chem Neuropathol 27: 195-210
15. De la Monte SM, Volicer L, Hauser SR, Wands JR (1992) Incresed levels of neuronal thread protein in cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol 32: 733-742
16. Elble R, Giacobini E, Scarsella GF (1987) Cholinesterases in cerebrospinal fluid. A longitudinal study in Alzheimer disease. Arch Neurol 44: 403-407
17. Galasko D, Clark C, Chang L, Miller B, Green RC, Motter R, Seubert P (1997) Assessmant of cerebrospinal fluid levels of tau in mildly demented patients with Alzheimer's disease. Neurology 48: 632-635
18. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI (1986) Abnormal phosphorylation of microtubule-associated protein tau in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83: 4913-4917
19. Gunnersen D, Haley B (1992) Detection of glutamine synthetase in the cerebrospinal fluid of Alzheimer diseased patients: a potential diagnostic biochemical marker. Proc Natl Acad Sci USA 89: 11949-11953
20. Hahne S, Nordsted C, Ahlin A, Nyback H (1997) Levels of cerebrospinal fluid apolipoprotein E in patients with Alzheimer's disease and healthy controls. Neurosci Lett 224: 99-102
21. Hampel H, Schoen D, Schwarz MJ, Kotter HU, Schneider C, Sunderland T, Dukoff R, Levy J, Padberg F, Stubner S, Buch K, Muller N, Moller HJ (1997) Interleukin-6 is not altered in cerebrospinal fluid of first-degree relatives and patients with Alzheimer's disease. Neurosci Lett 228: 143-146
22. Hawkins PN, Rossor MN, Gallimore JR, Miller B, Moore EG, Pepys MB (1994) Concentration of serum amyloid P component in the CSF as a possible marker of cerebral amyloid deposits in Alzheimer's disease. Biochem Biophys Res Commun 201: 722-726
23. Isoe K, Urakami K, Shimomura T, Wakutani Y, Ji Y, Adachi Y, Takahashi K (1996) Tau proteins in cerebrospinal fluid from patients with Alzheimer's disease: a longitudinal study. Dementia 7: 175-176
24. Jensen M, Basun H, Lannfelt L (1995) Increased cerebrospinal fluid tau in patients with Alzheimer's disease. J Neurol Sci 95: 239-258
25. Jimenez-Jimenez FJ, Debustos F, Molina JA, Benitoleon J, Tallonbaranco A, Gasalla T, Ortipareja M, Guillamon F, Rubio JC, Arenas J, Enriquezdesalamanca R (1997) Cerebrospinal fluid levels of alpha-tocopherol (Vitamin E) in Alzheimer's disease. J Neural Transm 104: 703-710
26. Kudo T, Iqbal K, Ravid R, Swaab DF, Grundke-Iqbal I (1994) Alzheimer disease: Correlation of cerebro-spinal fluid and brain ubiquitin levels. Brain Res 639: 1-7
27. Kuiper MA, Mulder C, Van Kamp GJ, Scheltens P, Wolters EC (1994) Cerebrospinal fluid ferritin levels of patients with Parkinsons's disease, Alzheimer's disease, and multiple system atrophy. J Neural Transm [P-D Sect] 7: 109-114
28. Landen M, Hesse C, Fredman P, Regland B, Wallin A, Blennow K (1996) Apolipoprotein E in cerebrospinal fluid from patients with Alzheimer's disease and other forms of dementia is reduced but without any correlation to the apoE4 isoform. Dementia 7: 273-278
29. Lannfelt L, Basun H, Vigo-Pelfrey C, Wahlund LO, Winblad B, Lieberburg I, Schenk D (1995) Amyloid beta-peptide in cerebrospinal fluid in individuals with the Swedish Alzheimer amyloid precursor protein mutation. Neurosci Lett 199: 203-206
30. Lefranc D, Vermersch P, Dallongeville J, Daems-Montpeurt C, Petit H, Delacourte A (1996) Relevance of the quantitation of apolipoprotein E in the cerebrospinal fluid in Alzheimer's disease. Neurosci Lett 212: 91-94
31. Licastro F, Parnetti L, Morini MC, Davis LJ, Cucinotta D, Gaiti A, Senin U (1995) Acute phase reactant alpha-1-antichymotrypsin is increased in cerebrospinal fluid and serum of patients with probable Alzheimer disease. Alz Dis Assoc Disord 9: 112-118
32. Lindh M, Blomberg M, Jensen M, Basun H, Lannfelt L, Engvall B, Scharnagel H, Marz W, Wahlund LO, Cowburn RF (1997) Cerebrospinal fluid apolipoprotein E (ApoE) levels in Alzheimer's disease patients are increased at follow-up and show a correlation with levels of tau protein. Neurosci Lett 229: 85-88
33. Loeffler DA, DeMaggio AJ, Juneau PL, Brickman CM, Mashour GA, Finkelman JH, Pomara N, LeWitt PA (1994) Ceruloplasmin is increased in cerebrospinal fluid in Alzheimer's disease but not Parkinson's disease. Alz Dis Assoc Disord 8: 190-197
34. Loeffler DA, Juneau PL, Nguyen HU, Najman D, Pomara N, LeWitt PA (1997) Immunocytochemical detection of anti-hippocampal antibodies in Alzheimer's disease and normal cerebrospinal fluid. Neurochem Res 22: 209-214
35. Lopez OL, Kaufer D, Reiter CT, Carra J, DeKosky ST, Palmer AM (1996) Relationship between CSF neurotransmitter metabolites and aggressive behavior in Alzheimer's disease. Eur J Neurol 3: 153-155
36. McRae A, Eng-Ang-Ling, Wigander A, Dahlstrom A (1993) Microglial cerebrospinal antibodies: significance for Alzheimer disease. Mol Chem Neuropathol 28: 98-95
37. Mehta PD, Thai L, Wisniewski HM, Grundke-Iqbal I, Iqbal K (1985) Paired helical filament antigen in CSF. Lancet ii: 35
38. Merched A, Blain H, Visvikis S, Herbeth B, Jeandel C, Siest G (1997) Cerebrospinal fluid apolipoprotein E level is increased in late-onset Alzheimer's disease. J Neurol Sci 145: 33-39
39. Mirra SS, Hart MN, Terry RD (1993) Making the diagnosis of Alzheimer's disease: a primer for practicing pathologists. Arch Pathol Lab Med 117: 132-144
40. Mochizuki Y, Oishi M, Hara M, Takasu T (1996) Amino acid concentration in dementia of the Alzheimer type and multi-infarct dementia. Ann Clin Lab Sci 26: 275-278
41. Molchan SE, Hill LJ, Martinez RA, Lawlor BA, Mellow AM, Rubinow DR, Bissette G, Nemeroff CB, Sunderland T (1993) CSF somatoatatin in Alzheimer's disease and major depression: relationship to hypothalamic-pituitary-adrenal axis and clinical measures. Psychoneuroendocrinology 18: 509-519
42. Mori H, Hosada K, Matsubara E, Nakamoto T, Furiya Y, Endih R, Usami M, Shoji M, Maruyama S, Hirai S (1995) Tau in cerebrospinal fluids: establishment of the sandwich ELISA with antibody to the repeat sequence in tau. Neurosci Lett 186: 181-183
43. Motter R, Vigo-Pelfrey C, Kholodenko D, Barbour R, Johnson-Wood K, Galasko D, Chang L, Miller B, Clark C, Green R, Olson D, Southwick P, Wolfert R, Munroe B, Lieberburg I, Seubert P, Schenk D (1995) Reduction of beta-amyloid peptide 42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol 38: 643-648
44. Munroe WA, Southwick PC, Chang L, Scharre DW, Echols CL, Jr, Fu PC, Whaley JM, Wolfert RL (1995) Tau protein in cerebrospinal fluid as an aid in the diagnosis of Alzheimer disease. Ann Clin Lab Sci 25: 207-217
45. National Institute on Aging and Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer's disease (1997) Consensus recommendations for the post mortem diagosis of Alzheimer's disease. Neurobiol Aging 18: S1-S3
46. Oishi M, Mochizuki Y, Yoshihashi H, Takasu T, Nakano E (1996) Laboratory examinations correlated with severity of dementia. Ann Clin Lab Sci 26: 340-345
47. Otto M, Wiltfang J, Tumani H, Zerr I, Lautsch M, Kornhuber J, Weber T, Kretschmer HA, Poser S (1997) Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurosci Lett 225: 210-212
48. Parnetti L, Gaiti A, Polidori MC, Brunetti M, Palumbo B, Chionne F, Cadini D, Cecchetti R, Senin U (1995a) Increased cerebrospinal fluid pyruvate levels in Alzheimer's disease. Neurosci Lett 199: 231-233
49. Parnetti L, Palumbo B, Cardinali L, Foreti F, Chionne F, Cechetti R, Senin U (1995b) Cerebrospinal fluid neuron-specific enolase in Alzheimer's disease and vascular dementia. Neurosci Lett 183: 43-45
50. Riemenschneider NM, Buch K, Schmolke M, Kurz A, Guder WG (1996) Cerebrospinal fluid tau is elevated in early Alzheimer's disease. Neurosci Lett 212: 209-211
51. Rosengren LE, Karlsson JE. Karlsson JO, Persson LI, Wikkels C (1996) Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF. J Neurochem 67: 2013-2018
52. Rosier N, Wichart I, Jellinger K (1996a) Total tau protein immunoreactivity in lumbar cerebrospinal fluid of patients with Alzheimer's disease. J Neurol Neurosurg Psychiatry 60: 237-238
53. Rosier N, Wichart I, Jellinger K (1996b) Intra vitam lumbar cerebrospinal fluid and serum and post mortem ventricular immunoreactive apolipoprotein E in patients with Alzheimer's disease. J Neurol Neurosurg Psychiatry 60: 452-454
54. Sahu RN, Pandey RS, Subhash MN, Arya BYT, Padmashree TS, Srinivas KN (1988) CSF zinc in Alzheimer's type dementia. Biol Psychiatry 24: 480-482
55. Schröder J, Pantel J, Ida N, Essig M, Hartmann T, Knopp MV, Schad LR, Sandbrink R, Sauer H, Masters CL, Beyreuther K (1997) Cerebral changes and cerebrospinal fluid beta-amyloid in Alzheimer's disease: a study with quantitative magnetic resonance imaging. Mol Psychiat 2: 505-507
56. Shen ZX (1996) The significance of the activity of CSF cholinesterases in dementias. Med Hypotheses 47: 363-376
57. Shen ZX, Ding Q, Wei CZ, Ding MC, Meng JM (1993) CSF cholinesterase in early-onset and late-onset Alzheimer's disease and multi-infarct dementia of Chinese patients. Acta Neurol Scand 87: 19-24
58. Shetti HU, Holloway HW, Schapiro MB (1996) Cerebrospinal fluid and plasma distribution of myo-inositol and other polyols in Alzheimer disease. Clin Chem 42: 298-302
59. Skoog I, Hesser C, Fredman P, Andreasson LA, Palmertz B, Blennow K (1997) Apolipoprotein E in cerebrospinal fluid in 85-year-old subjects - relation to dementia, apolipoprotein E polymorphism, cerebral atrophy, and white matter lesions. Arch Neurol 54: 267-272
60. Smyth MD, Cribbs DH, Tenner AJ, Rodman-Shankle W, Dick M, Kesslak JP, Cotman CW (1994) Decreased levels of C1q in cerebrospinal fluid of living Alzheimer patients correlate with disease state. Neurobiol Aging 15: 609-614
61. Soininen H, Lehtovirta M, Helisalmi S, Linnaranta K, Heinonen O, Riekinnen Sr P (1995) Increased acetylcholinesterase activity in the CSF of Alzheimer patients carrying apolipoprotein epsilon 4 allele. NeuroReport 6: 2518-2520
62. Song H, Saito K, Seishima M, Noma A, Urakami K, Nakashima K (1997) Cerebrospinal fluid Apo E and Apo A1 concentrations in early and late-onset Alzheimer's disease. Neurosci Lett 231: 175-178
63. Southwick PC, Yamagata SK, Echols Jr CL, Higson GJ, Neynaber SA, Parson RE, Munroe WA (1996) Assessment of amyloid beta protein in cerebrospinal fluid as an aid in the diagnosis of Alzheimer's disease. J Neurochem 66: 259-265
64. Strittmatter M, Hamann GF, Grauer MT, Cramer H, Schimrigk K (1997a) Neurochemical differences in the CSF between Binswanger's and Alzheimer's disease. Dementia Geriatr Cogn Disord 8: 34-42
65. Strittmatter M, Cramer H, Reuner C, Strubel D, Hamann G, Schimrigk K (1997b) Molecular forms of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with senile dementia of the Alzheimer type. Biol Psychiatry 41: 1124-1130
66. Tamaoka A, Sawamura N, Fukushima T, Shoji S, Matsubara E, Shoji M, Hirai S, Furiya Y, Endoh H, Mori H (1997) Amyloid beta protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease. J Neurol Sci 148: 4-45
67. Tapiola T, Lehtovirta M, Ramberg J, et al. (1998) CSF tau is related to apolipoprotein E genotype in early Alzheimer's disease. Neurology 50: 169-174
68. Tato RE, Frank A, Hernanz A (1995) Tau protein concentrations in cerebrospinal fluid of patients with dementia of the Alzheimer type. J Neurol Neurosurg Psychiatry 59: 280-283
69. Toghi H, Abe T, Hashiguchi K, Saheki M, Takahashi S (1994) Remarkable reduction in acetylcholine concentration in the cerebrospinal fluid from patients with Alzheimer type dementia. Neurosci Lett 177: 1-2: 139-142
70. Toghi H, Abe T, Kimura M, Saheki M, Takahashi S (1996) Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia. J Neural Transm 103: 1211-1220
71. Vandermeeren M, Mercken M, Vanmechelen E, Six J, Van-de-Voorde A, Martin JJ, Cras P (1993) Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay. J Neurochem 61: 1828-1834
72. Wisniewski HM, Mehta PD, Kim KS, Merz GS (1989) Cerebrospinal fluid based laboratory test for Alzheimer disease. In: Christen Y (ed) Research and perspectives in Alzheimer disease. Biological markers of Alzheimer disease. Springer, Berlin Heidelberg New York Tokyo, pp 23-29
73. Yamada K, Kono K, Umegaki H, Yamada K, Iguchi A, Fukatsu T, Nakashima N, Nishiwaki H, Shimada Y, Sugita Y, Yamamoto T, Hasegawa T, Nabeshima T (1995) Decreased interleukin-6 level in the cerebrospinal fluid of patients with Alzheimer-type dementia. Neurosci Lett 186: 219-221
74. Yasuda M, Maeda K, Kakigi T, Minamitani N, Kawaguchi T, Tanaka C (1995) Low cerebrospinal fluid concentrations of peptide histidine valine and somatostatin-28 in Alzheimer's disease: Altered processing of prepro-vasoactive intestinal polypeptide and prepro-somatostatin. Neuropeptides 29: 325-330